Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
Early, upfront planning of your clinical supply chain is critical to ensuring programs effectively balance risk and cost. When resources are limited and time is essential, early planning can optimize key parameters for study supplies including risk mitigation strategies to avoid stock outs and study delays, minimizing waste with optimized inventory, and forecasting demand to facilitate robust supply planning. Join Simon Caviezel, Program Director for Thermo Fisher Scientific to uncover the benefits and best practices to progress your clinical program smoothly from start to finish.